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Abstract
Introduction:  HTLV-1  infection  is  endemic  in  Japan,  Caribbean,  Africa,  and  South  America.
It is  transmitted  from  mother  to  child,  sexual  contact,  blood  transfusions,  or  sharing  needles.
Tropical  spastic  paraparesis  (TSP)  is  a  chronic  degenerative  neurological  disease  associated  with
this infection.  It  results  from  a  spinal  cord  symmetrical  degeneration  at  the  thoracic  level  and
is characterized  by  progressive  motor  weakness  in  the  lower  limbs,  hyperreﬂexia,  sensitivity
changes, urinary  incontinence,  and  bladder  dysfunction.
Clinical  case: Female,  53  years  old,  HTLV-1  infection  and  TSP.  She  had  decreased  strength  in
the lower  limbs  and  hyperreﬂexia,  paretic  gait,  spasticity,  and  neurogenic  bladder  symptoms,
with recurrent  urinary  infections.  She  was  scheduled  for  cystectomy.  The  patient  was  monitored
according  to  standard  ASA.  Due  to  severe  coagulopathy  and  the  possibility  of  neurological  wors-
ening, epidural  catheter  was  not  placed.  The  induction  of  general  anesthesia  was  performed
with midazolam  and  fentanyl,  followed  by  etomidate  and  cisatracurium.  She  was  intubated  with
a tube  size  seven  and  maintained  with  desﬂurane  and  oxygen.  Anesthesia  was  uneventful;  the
surgery lasted  1  hour  and  50  min.  There  were  no  complications  in  the  immediate  postoperative
period, during  hospitalization,  nor  deterioration  of  the  neurological  examination.  The  patient
was discharged  20  days  later.
Discussion/Conclusion:  There  are  reports  of  decreased  electromyographic  response  and  neu-
rological deterioration  associated  with  propofol  in  these  patients,  etomidate  was  used.  The
hepatic metabolism  of  rocuronium  posed  a  risk,  we  chose  to  use  cistracurium.  It  was  concluded
that the  anesthesia  chosen  did  not  affect  the  course  of  the  disease.
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Resumo
Introduc¸ão:  A  infecc¸ão  por  HTLV-  1  é  endêmica  no  Japão,  nas  Caraíbas,  na  África  e  na  América
do Sul.  A  transmissão  ocorre  de  mãe  para  ﬁlho,  por  contatos  sexuais,  transfusões  de  sangue  ou
partilha de  agulhas.  A  essa  infec¸ão  está  associada  uma  doenc¸a  neurológica  degenerativa  crônica,
a paraparesia  espástica  tropical  (TSP).  Essa  resulta  de  uma  degenerac¸ão  simétrica  da  espinal
medula em  nível  torácico.  Caracteriza-se  por  diminuic¸ão  progressiva  da  forc¸a nos  membros
inferiores,  hiperreﬂexia,  alterac¸ões  de  sensibilidade,  incontinência  urinária  e  disfunc¸ão  vesical.
Caso clínico: Mulher  de  53  anos,  infecc¸ão  por  HTLV-1  e  TSP.  Apresentava  diminuic¸ão  da  forc¸a
nos membros  inferiores  e  hiperreﬂexia,  tinha  uma  marcha  parética,  espasticidade  e  sintomas
de bexiga  neurogênica  com  infecc¸ões  urinárias  de  repetic¸ão.  Foi  proposta  para  cistectomia.
Foi monitorada  de  acordo  com  o  padrão  da  ASA.  Devido  à  coagulopatia  grave  e  à  possibilidade
de agravamento  neurológico,  não  se  colocou  cateter  epidural.  A  induc¸ão  da  anestesia  geral  foi
feita com  midazolam  e  fentanil  seguidos  de  etomidato  e  cisatracúrio.  Foi  entubada  com  um  tubo
sete e  mantida  com  desﬂurano  e  oxigênio.  A  anestesia  decorreu  sem  intercorrências,  a  cirurgia
terminou em  uma  hora  e  50  minutos.  Não  houve  quaisquer  complicac¸ões  no  pós-operatório
imediato,  durante  a  internac¸ão,  nem  deteriorac¸ão  do  exame  neurológico.  A  doente  teve  alta
20 dias  depois.
Discussão/Conclusão:  Há  relatos  de  diminuic¸ão  da  resposta  eletromiográﬁca  e  deteriorac¸ão
neurológica  associadas  ao  propofol  nesses  doentes,  razão  para  uso  de  etomidato.  A
metabolizac¸ão hepática  do  rocurônio  representava  um  risco  e  se  optou  pelo  cisatracúrio.
Conclui-se  que  o  plano  anestésico  escolhido  não  teve  qualquer  interferência  no  curso  da  doenc¸a.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.
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sis,  but  due  to  the  atypical  clinical  course  and  the  presencentroduction
he  human  T-lymphotropic  virus  1  (HTLV-1)  infection  is
ndemic  in  some  countries,  notably  in  Japan,  Caribbean
ountries,  and  parts  of  Africa  and  South  America.  The
revalence  increases  with  age  and  is  higher  in  females.1
t  is  transmitted  from  mother  to  child,  by  sexual  contact,
lood  transfusions,  or  sharing  contaminated  needles.  Two
iseases  are  associated  with  this  infection:  adult  T-cell
eukemia/lymphoma  (ATL)  and  tropical  spastic  parapare-
is  (TSP)  --  a  chronic  degenerative  neurological  disorder.
SP  results  from  symmetrical  degeneration  of  the  spinal
ord  lateral  columns  at  the  thoracic  level.2 It  is  charac-
erized  by  progressive  motor  weakness  in  the  lower  limbs
nd  hyperreﬂexia,  associated  with  autonomic  dysfunction
ith  urinary  incontinence  and  bladder  dysfunction.  Changes
n  gait  due  to  decreased  strength  in  the  lower  limbs  are
he  main  symptom  of  disease.  Autonomic  dysfunction  symp-
oms  may  precede,  be  concomitant,  or  be  manifested
ater  in  disease  progression.  Noteworthy,  the  symptoms  ofPlease  cite  this  article  in  press  as:  Rodrigues  M,  et  al.  Tropi
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2014.12.
eurogenic  bladder,  which  results  in  high  mortality  rates,
specially  feeling  of  incomplete  emptying,  pollakiuria,  uri-
ary  urgency,  recurrent  urinary  tract  infections,  gallstones,
o
H
And  even  severe  cases  of  chronic  pyelonephritis  or  kidney
ailure.3
Unlike  the  multiple  sclerosis  (MS),  the  symptoms
evelop  gradually,  without  periods  of  crisis  and  remission.
urthermore,  there  is  no  involvement  of  the  cranial  nerves
nd  cognitive  function.  This  syndrome  develops  in  less  than
%  of  those  infected  by  HTLV-1.1
Current  knowledge  of  the  anesthetic  management  of
hese  patients  results  from  clinical  isolated  rare  cases.  The
im  of  this  paper  is  to  present  a  case  of  TSP  and  expose  its
nesthetic  approach.
ase report
emale  patient,  53  years  old,  60  kg,  158  cm,  with  TSP  of
everal  years  of  development  and  diagnosed  seven  years
efore,  presented  with  complaints  of  decreased  strength
n  the  lower  limbs  for  about  15  years  and  delayed  urinary
ymptoms.  Initially,  she  was  diagnosed  with  multiple  sclero-cal  spastic  paraparesis  --  anesthetic  approach.  Rev  Bras
004
f  HTLV-1  antibodies  in  blood  and  cerebral  spinal  ﬂuid  (CSF),
TLV-1  infection  was  conﬁrmed.  Cystectomy  was  proposed.
t  the  time  of  surgery,  the  patient  was  neurologically  stable.
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Tropical  spastic  paraparesis  --  anesthetic  approach  
She  had  bilateral  decreased  strength  in  the  lower  limbs,
hyperreﬂexia,  and  no  sensitivity  changes;  walked  with  third-
party  support;  had  a  paretic  march,  with  spasticity;  had
no  changes  of  cranial  nerves  or  upper  limbs.  She  also  had
symptoms  of  neurogenic  bladder  with  recurrent  urinary,  an
indication  to  undergo  the  surgery  in  question.  Her  personal
history  included  infection  with  hepatitis  C  with  thrombo-
cytopenia  (37  ×  109 L−1 platelets)  and  severe  coagulation
disorders  (aPTT  38.6,  TP  13.8),  type  2  diabetes,  and  depres-
sive  syndrome.  The  remaining  preoperative  tests  (analytical
study,  ECG,  chest  X-ray,  and  kidney  function  test)  were  nor-
mal.
Anesthesia
Monitoring:  ASA  standards,  BIS,  and  TOF.
Premedication:  midazolam.
It  was  decided  not  to  insert  an  epidural  catheter  due  to
patients’  severe  coagulopathy  and  the  possibility  of  neuro-
logical  worsening.
Induction:  Fentanyl  followed  by  etomidate  and
cisatracurium.  Intubation  with  a  tube  size  seven.
Maintenance:  General  anesthesia  (GA)  was  maintained
with  desﬂurane  and  oxygen.  Two  additional  bolus  of
cisatracurium  were  given  according  to  TOF.
Induction  and  maintenance  of  anesthesia  were  unevent-
ful:  Due  to  technical  difﬁculties,  the  surgical  team  chose
not  to  perform  the  initially  scheduled  radical  cystectomy.
A  cystostomy  was  performed,  and  the  procedure  lasted  one
hour  and  50  min.
Recovery:  The  neuromuscular  blockade  was  reversed
with  neostigmine  and  atropine  and,  ﬁve  minutes  later,  the
patient  had  400  mL  tidal  volume,  respiratory  rate  12  bpm,
and  was  wide  awake,  so  she  was  extubated  in  the  operating
room.  There  were  no  complications  in  the  immediate  post-
operative  period,  during  hospitalization,  or  deterioration  of
the  neurological  examination.  The  patient  was  discharged
20  days  later.
Discussion and anesthetic considerations
Patients  with  tropical  spastic  paraparesis  have  numer-
ous  complications  resulting  from  the  disease  progression;
notably,  infected  scabs  of  prolonged  recumbency,  uri-
nary  retention  due  to  sphincter  dysfunction,  and  fractures
resulting  from  peripheral  neuropathy,  which  predominantly
affects  the  lower  limbs.  They  are,  therefore,  potential  sur-
gical  candidates.
In  recent  years,  and  mainly  the  result  of  thematic
review  articles  or  case  reports  in  endemic  regions,  we
have  sought  to  understand  the  implications  and  anesthetic
needs  of  these  patients,  avoid  exacerbations/crisis  or  post-
surgical  complications.  Thus,  the  anesthetic  management
of  these  patients  should  take  into  account  some  specialPlease  cite  this  article  in  press  as:  Rodrigues  M,  et  al.  Tropi
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2014.12.0
features.
Many  of  these  patients  are  under  daily  corticosteroids,4
and  need  to  keep  doses  not  below  the  usual  during  the  peri-
operative  period  (hydrocortisone  200  mg  in  major  surgery
2 PRESS
3
nd  100  mg  in  minor  surgery)  due  to  the  risk  of  left  ventri-
ular  dysfunction  and  refractory  hypotension.
Classically,  the  neuraxial  anesthetic  approach  is  con-
raindicated  in  patients  with  active  disease  or  active
eurological  symptoms.  However,  there  are  several  reports
f  neuraxial  anesthesia  in  patients  with  TSP,  without  dete-
ioration  of  neurological  symptoms,  or  accelerated  disease
rogression.3
Some  authors  have  reported  that  the  induction  doses  of
ropofol  (2--3  mg  kg−1)  causes  decreased  electromyographic
ctivity  (about  20%)  in  patients  with  TSP,  without,  however,
ecreased  muscle  strength  or  neuronal  conduction  velocity.5
The  choice  of  neuromuscular  relaxant  to  use  in  such
atients  is  also  a  subject  of  great  controversy.  The  pres-
nce  of  a  high  number  of  muscle  cholinergic  receptors  out  of
he  neuromuscular  plate  on  these  patients  greatly  increases
he  sensitivity  to  acetylcholine.  Thus,  the  use  of  depolariz-
ng  muscle  relaxants,  such  as  succinylcholine,  carries  a  high
isk  of  severe  hyperkalemia  (increase  of  about  3 mmol  L−1)
hat  may  result  in  cardiac  arrest.  If  necessary,  the  group
f  nondepolarizing  muscle  relaxants  should  be  preferred,
lthough  these  patients  often  exhibit  a  prolonged  action.
hus,  neuromuscular  block  monitoring  is  essential.
The  choice  of  the  technique  and  anesthetic  protocol  in
his  patient  took  into  account  the  current  recommendations
or  patients  with  known  myelopathy.  Neuraxial  anesthesia
as  discarded  due  to  coagulopathy  and  risks  of  exacer-
ation/disease  progression.  The  selected  drugs,  notably
nducing  and  relaxing  drugs,  minimize  the  risk  of  serious
erioperative  complications.
onclusions
ropical  spastic  paraparesis  is  a  rare  neurological  compli-
ation  of  HTLV-1  infection,  is  endemic  in  Japan,  Colombia,
razil  and  Caribbean  countries.  It  is  characterized  by  slow
nd  progressive  spasticity,  hyperreﬂexia,  muscle  weakness
ainly  in  the  lower  limbs,  bladder  disorders,  and  changes  in
ensitivity.
The  management  of  these  patients  is  challenging.  Usu-
lly,  general  anesthesia  is  selected  at  the  expense  of
euraxial  anesthetic  techniques  due  to  the  possibility  of  dis-
ase  exacerbation.  The  choice  of  the  induction  drug  and
specially  the  muscle  relaxant  (wherever  possible,  avoid  the
epolarizing  relaxants)  is  essential  to  prevent  major  periop-
rative  complications  that  prolong  hospitalization  and  result
n  the  progression  of  disease  activity.  Careful  monitoring  of
he  neuromuscular  block  is  essential  and  indisputable.
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